
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.
This had a negative US experience, which he sees turning around in the 2nd half. Just missed on the 2nd quarter. The Asian business is doing well being up 16%. He models them growing earnings at 7% compounded annually over the next couple of years. A little more expensive than Manulife (MFC-T), but coming much closer. Longer-term, this is fine. All things being equal, he would be buying it closer to $45.
Canadian Banks versus lifecos? He is a bigger fan of the lifecos. Manulife (MFC-T) and Sun Life (SLF-T) are going to get a big boost from rising interest rates. It is already starting to happen. The yield curve is steepening. Lifecos have been suffering and living with low interest rates for a long time. Both companies are also quite global. They have big presences in the US and in Asia. He sees a better earnings growth over the next few years.